Maria R. Marques
Valencia, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients.
Journal: Thrombosis research
Published: January 21, 2021
Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.
Journal: Acta paediatrica (Oslo, Norway : 1992)
Published: May 06, 2019
Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate® ) and BAY 81-8973 (Kovaltry® ) in patients with severe or moderate haemophilia A in prophylaxis.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: January 18, 2019
Impact of voriconazole plasma concentrations on treatment response in critically ill patients.
Journal: Journal of clinical pharmacy and therapeutics
Published: October 16, 2018
Influence of pharmacokinetic/pharmacodynamic ratio on vancomycin treatment response in pediatric patients with Staphylococcus aureus bacteremia.
Journal: Minerva pediatrics
Published: April 14, 2018
The prion-related protein (testis-specific) gene (PRNT) is highly polymorphic in Portuguese sheep.
Journal: Animal genetics
Published: September 10, 2015
SNPs and taxane toxicity in breast cancer patients.
Journal: Pharmacogenomics
Published: December 16, 2014
Increased hospital stay and allograft dysfunction in renal transplant recipients with Cyp2c19 AA variant in SNP rs4244285.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: November 24, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026